Sign in
PAVMW Stock Price, Chart, Stats & News
PAVmed Inc.
Save
PAVmed Inc. (PAVMW) does not currently pay a dividend.
769,747
Market cap
–
Current P/E
–
Forward P/E
PAVMW chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | -668.97% |
Operating margin | -69627.59% |
Pretax margin | 4931.03% |
Net margin | 10672.41% |
Effective tax rate | – |
ROA | 8.13% |
ROE | 10.23% |
D/E | 0.26x |
Interest coverage ratio | -877.91x |
PAVMW valuation
P/E | – |
P/S | 160.56x |
P/B | 0.17x |
P/CF | -0.00x |
P/FCF | -0.00x |
P/OCF | -0.00x |
PEG | -0.02x |
EV multiple | -0.95x |
About
PAVmed Inc. is a U. S.-based company that develops and commercializes innovative medical technologies. Its core product offerings include CarpX, a minimally invasive device designed for treating carpal tunnel syndrome, and EsoCheck, an advanced system for collecting esophageal cells to aid in the early identification of esophageal adenocarcinoma and Barrett's Esophagus (BE).
Similar securities
Based on sector and market capitalization
Report issue